Allergy, ENT, and immunology practices must follow USP 797 when mixing patient-specific allergen extracts for subcutaneous immunotherapy (ACAAI 2023). Section 21 of USP 797 outlines the requirements for compounding allergen extracts to minimize the risk of contamination and ensure the patient’s overall health is protected. USP 797 requirements apply to mixing allergen extracts for… Learn More
USP 797 defines proper sterile compounding procedures for compounded sterile preparations (CSPs) including injections, infusions, and IV bags. All applicable facilities must follow USP 797 guidelines to help preserve medication quality. USP 797 sterile compounding rules apply to “hospitals, other healthcare facilities, patient treatment sites, infusion facilities, pharmacies, and physicians/veterinarians practice sites” (USP 2022). Infusion… Learn More
Made in the USA